Silná menorrhagie způsobená děložním myomem a adenomyózou v perimenopauze – úspěšná terapie perorálním GnRH antagonistou s kombinovanou terapií jedenkrát denně

Stáhnout PDF English version

Autoři: J. Racková ^1,2
Působiště autorů: Department of Obstetrics and Gynaecology, University Hospital Bulovka, Prague, Czech Republic ¹; Gynem s. r. o., Prague, Czech Republic ²
Vyšlo v časopise: Ceska Gynekol 2023; 88(2): 135-138
Kategorie: Komerčně podpořené sdělení

Zdroje

1. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet 2020; 149 (1): 3–9. doi: 10.1002/ijgo.13102.

2. Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2016; 34 : 13–24. doi: 10.1016/j.bpobgyn.2015.11.015.

3. Bachmann GA, Bahouth LA, Amalraj P et al. Uterine fibroids: correlations of anemia and pain to fibroid location and uterine weight. J Reprod Med 2011; 56 (11–12): 463–466.

4. Crha K, Ješeta M, Pilka R et al. Adenomyosis –⁠ its possible effect on endometrial function and receptivity. Ceska Gynekol 2021; 86 (3): 205–209. doi: 10.48095/cccg2021205.

5. Weiss G, Maseelall P, Schott LL et al. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women’s Health Across the Nation (SWAN). Fertil Steril 2009; 91 (1): 201–206. doi: 10.1016/ j.fertnstert.2007.11.025.

6. Taran FA, Weaver AL, Coddington CC et al. Understanding adenomyosis: a case control study. Fertil Steril 2010; 94 (4): 1223–1228. doi: 10.1016/j.fertnstert.2009.06.049.

7. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016; 22 (6): 665–686. doi: 10.1093/humupd/dmw023.

8. Stewart EA, Lukes AS, Venturella R et al. Relugolix combination therapy for uterine leiomyoma-associated pain in the LIBERTY randomized trials. Obstet Gynecol 2022; 139 (6): 1070–1081. doi: 10.1097/AOG.0000000000004 787.

9. Giudice LC, As-Sanie S, Arjona Ferreira JC et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet 2022; 399 (10343): 2267–2279. doi: 10.1016/S0140-6736 (22) 00622-5.

10. Laughlin-Tommaso SK, Stewart EA. Moving toward individualized medicine for uterine leiomyomas. Obstet Gynecol 2018; 132 (4): 961–971. doi: 10.1097/AOG.0000000000002 785.

11. Altman D, Granath F, Cnattingius S et al. Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study. Lancet 2007; 370 (9597): 1494–1499. doi: 10.1016/S01 40-6736 (07) 61635-3.